Bluesky Facebook Reddit Email

New Ultrasound Contrast Agent Leads To Full Patient Recovery

A new ultrasound contrast agent, Levovist, has been used to treat an ischemic stroke in a German patient. The agent revealed the blocked artery and allowed doctors to dissolve the clot with thrombolytic rTPA, restoring blood flow to the brain within 40 minutes of admission.

New Software Simulates How Blood Clots Dissolve

Researchers developed CLOTSIM, a computer model simulating blood clot dissolution, to provide critical information on thrombolytic agents. The program helps predict clinical outcomes and tailor therapies to reduce patient risks.